The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 1)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 1)
-
ナレーター：
-
著者：
Medical care and scientific research offer some of the most challenging – and developing – areas for global supply chain logistics. And few are more significant– in terms of potential for improving human life and logistics precision required – than Cell & Gene Therapy or CGT.
These CGT “medical miracles” bring logistics opportunities and challenges, around timing, temperature, chain of identity, synchronization, integration, scale, back up planning, and more.
So, what is required – logistically – to help ensure CGT clinical trials and personalized therapies get handled safely, securely, and on time?
QuickSTAT's Global Head of Strategy for CGT and DTP, Mike Sweeney and Senior VP of Commercial Operations Scott Ohanesian explain.
For more information on clinical trial logistics, visit our website at quickstat.com.